Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1051899-73-0 | MDL No. : | MFCD11846488 |
Formula : | C7H8FNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DHBSPQXMPAFUKP-UHFFFAOYSA-N |
M.W : | 141.14 | Pubchem ID : | 53249229 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 36.93 |
TPSA : | 46.25 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.83 cm/s |
Log Po/w (iLOGP) : | 1.11 |
Log Po/w (XLOGP3) : | 0.46 |
Log Po/w (WLOGP) : | 1.18 |
Log Po/w (MLOGP) : | 1.31 |
Log Po/w (SILICOS-IT) : | 1.38 |
Consensus Log Po/w : | 1.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.38 |
Solubility : | 5.84 mg/ml ; 0.0414 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.0 |
Solubility : | 14.1 mg/ml ; 0.1 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.12 |
Solubility : | 1.07 mg/ml ; 0.00757 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.02 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With hydrogen In ethyl acetate for 1 h; | NMR Spectrum (DMSOd6): 4.34 (d, 2H), 4.74 (bs, 2H), 5.12 (t, IH), 6.59 (dd, IH), 6.77 (ddd, IH), 6.91 (dd, IH)(3-nitro-2-fluorophenyl)methanol (2.1 g, 12.28 mmol) in solution in AcOEt was reduced with hydrogen (30 Psi) in presence of Pt/C over Ih. The catalyst was removed by filtration and the solvent evaporated to give (3-amino-2-fluorophenyl)methanol as a yellow solid. (1.64 g, 95percent) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50.1% | Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; Inert atmosphere Stage #2: With methanol In tetrahydrofuranInert atmosphere |
Intermediate 101: (3-amino-2-fluorophenyl)methanol 3-amino-2-fluorobenzoic acid (APIN, 250 mg, 1.612 mmol) was dissolved in 10 mL of anhydrous THF under N2 atmosphere. Solution was cooled at 0° C. in an ice-water bath. LiAlH4 (FLUKA, 183 mg, 4.83 mmol) was added. Reaction was stirred under nitrogen at room temperature. After 2 h one equivalent of LiAlH4 (FLUKA, 61 mg, 1.62 mmol) was added to the mixture and reaction was stirred at room temperature overnight. Another equivalent of LiAlH4 (FLUKA, 61 mg, 1.62 mmol) was added. After 5 h The reaction mixture was quenched by adding MeOH. Solvent was evaporated to obtain an orange syrup that was dissolved in EtOAc and partitioned with saturated NaHCO3 (aqueous) (10 mL of saturated solution+15 mL of distilled water). Aqueous phase was extracted with EtOAc, organic layers were combined and dried with MgSO4 (anh), filtered off and concentrated. Crude was purified using silica gel cartridge with linear gradient 0-85percent DCM/MeOH to yield the title compound (114 mg, 0.808 mmol, 50.1percent yield) as yellow syrup. 1H NMR (300 MHz, DMSO-d6) δ ppm: 6.50-6.85 (m, 3H), 4.95-5.08 (m, 3H), 4.44 (d, 2H). |
[ 84832-00-8 ]
(5-Amino-2-fluorophenyl)methanol
Similarity: 0.93
[ 227609-86-1 ]
(3-Amino-4-fluorophenyl)methanol
Similarity: 0.93
[ 748805-85-8 ]
(2-Amino-5-fluorophenyl)methanol
Similarity: 0.84
[ 1260783-44-5 ]
(2-Amino-4,6-difluorophenyl)methanol
Similarity: 0.83
[ 84832-00-8 ]
(5-Amino-2-fluorophenyl)methanol
Similarity: 0.93
[ 227609-86-1 ]
(3-Amino-4-fluorophenyl)methanol
Similarity: 0.93
[ 748805-85-8 ]
(2-Amino-5-fluorophenyl)methanol
Similarity: 0.84
[ 1260783-44-5 ]
(2-Amino-4,6-difluorophenyl)methanol
Similarity: 0.83
[ 84832-00-8 ]
(5-Amino-2-fluorophenyl)methanol
Similarity: 0.93
[ 227609-86-1 ]
(3-Amino-4-fluorophenyl)methanol
Similarity: 0.93
[ 748805-85-8 ]
(2-Amino-5-fluorophenyl)methanol
Similarity: 0.84
[ 1260783-44-5 ]
(2-Amino-4,6-difluorophenyl)methanol
Similarity: 0.83
[ 906811-49-2 ]
(2-Amino-3-fluorophenyl)methanol
Similarity: 0.79
[ 84832-00-8 ]
(5-Amino-2-fluorophenyl)methanol
Similarity: 0.93
[ 227609-86-1 ]
(3-Amino-4-fluorophenyl)methanol
Similarity: 0.93
[ 748805-85-8 ]
(2-Amino-5-fluorophenyl)methanol
Similarity: 0.84
[ 1260783-44-5 ]
(2-Amino-4,6-difluorophenyl)methanol
Similarity: 0.83